Arian Resources Corp.
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, th… Read more
Market Cap & Net Worth: Arian Resources Corp. (ARC)
Arian Resources Corp. (V:ARC) has a market capitalization of $462.40K (CA$664.12K) as of March 18, 2026. Listed on the V stock exchange, this Canada-based company holds position #37914 globally and #459 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arian Resources Corp.'s stock price CA$0.01 by its total outstanding shares 66411840 (66.41 Million).
Arian Resources Corp. Market Cap History: 2025 to 2026
Arian Resources Corp.'s market capitalization history from 2025 to 2026. Data shows growth from $462.40K to $462.40K (0.00% CAGR).
Arian Resources Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arian Resources Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ARC by Market Capitalization
Companies near Arian Resources Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to Arian Resources Corp. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Arian Resources Corp. Historical Marketcap From 2025 to 2026
Between 2025 and today, Arian Resources Corp.'s market cap moved from $462.40K to $ 462.40K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$462.40K | 0.00% |
| 2025 | CA$462.40K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Arian Resources Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $462.40K USD |
| MoneyControl | $462.40K USD |
| MarketWatch | $462.40K USD |
| marketcap.company | $462.40K USD |
| Reuters | $462.40K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.